Ependymal Tumor

• Ependymal Tumor originates from ependymal cells lining the brain’s ventricles and spinal cord.
• Symptoms vary significantly based on the tumor’s location, ranging from headaches and seizures to back pain and neurological deficits.
• Diagnosis primarily involves MRI scans and is confirmed through a biopsy, with tumors graded according to WHO classifications.
• Treatment typically begins with surgical removal, often followed by radiation therapy, especially for higher-grade tumors.
• The ependymal tumor prognosis and outlook depend on factors like tumor grade, location, and the extent of surgical resection.

What Is Ependymal Tumor?

An Ependymal Tumor is a primary central nervous system tumor that develops from ependymal cells. These specialized cells form the lining of the brain’s fluid-filled cavities, known as ventricles, and the central canal of the spinal cord. While they can occur anywhere along the neuroaxis, ependymal tumors are most frequently found in the posterior fossa (the back part of the brain) in children and in the spinal cord in adults. According to the World Health Organization (WHO), ependymal tumors are classified into different grades based on their aggressiveness, ranging from benign (Grade I) to highly malignant (Grade III), with Grade II being the most common type.

These tumors are relatively rare, accounting for approximately 2% to 3% of all primary brain and spinal cord tumors. In children, however, they represent about 5% to 10% of all pediatric brain tumors, making them one of the more common types of brain tumors in this age group. The exact cause of ependymal tumors is not fully understood, but research continues to explore potential genetic and environmental factors.

Ependymal Tumor Symptoms and Diagnosis

The symptoms of an ependymal tumor symptoms and diagnosis are highly dependent on its location and size. Tumors in the brain can block the flow of cerebrospinal fluid (CSF), leading to a buildup of pressure known as hydrocephalus. This can manifest as:

• Persistent headaches, often worse in the morning
• Nausea and vomiting
• Vision problems (e.g., double vision)
• Balance and coordination difficulties
• Seizures
• Changes in mood or personality

Spinal cord ependymal tumors, on the other hand, can compress nerves, causing symptoms such as localized back pain, weakness or numbness in the limbs, and bladder or bowel dysfunction. Due to the varied presentation, diagnosis often begins with a neurological examination and advanced imaging techniques. Magnetic Resonance Imaging (MRI) is the preferred method for visualizing the tumor, determining its size, and assessing its relationship to surrounding structures. A definitive diagnosis, including tumor grading, is established through a biopsy, where a small tissue sample is surgically removed and examined under a microscope by a neuropathologist.

Treatment Options and Outlook for Ependymal Tumors

The primary treatment for ependymal tumor treatment options is surgical resection, aiming for the greatest possible removal of the tumor while preserving neurological function. Complete surgical removal is a critical factor in improving patient outcomes. Following surgery, radiation therapy is often recommended, especially for high-grade tumors or when complete resection is not achieved. Radiation helps to destroy remaining tumor cells and reduce the risk of recurrence. Chemotherapy is generally less effective for ependymal tumors compared to other brain tumors, but it may be considered in specific cases, such as for very young children or recurrent tumors, often as part of clinical trials.

The ependymal tumor prognosis and outlook vary significantly based on several factors, including the tumor’s grade (WHO I, II, or III), its location, the extent of surgical removal, and the patient’s age. Lower-grade tumors (Grade I and II) that are completely resected generally have a more favorable prognosis. For instance, five-year survival rates for completely resected Grade II ependymomas can be as high as 70-80%, while Grade III (anaplastic) ependymomas have a less favorable outlook, often requiring more aggressive treatment strategies. Regular follow-up MRI scans are essential after treatment to monitor for any signs of recurrence. A multidisciplinary team approach, involving neurosurgeons, radiation oncologists, medical oncologists, and neurologists, is crucial for developing a comprehensive and individualized treatment plan.